Table 2.
Characteristics of oncologists in the pre- and post–COVID-19 patient-sharing networks.
| Characteristic | Patient-sharing network type | |||||||||||
|
|
|
Breast cancer | Colorectal cancer | Lung cancer | ||||||||
|
|
|
Before COVID-19 (n=78) | Post COVID-19 (n=77) | P value | Before COVID-19 (n=72) | Post COVID-19 (n=66) | P value | Before COVID-19 (n=77) | Post COVID-19 (n=54) | P value | ||
| Specialty, n (%) | ||||||||||||
|
|
Medical oncology | 33 (42) | 29 (38) | .83 | 35 (49) | 33 (50) | .99 | 36 (47) | 27 (50) | .50 | ||
|
|
Radiation oncology | 10 (13) | 10 (13) |
|
9 (12) | 8 (12) |
|
10 (13) | 10 (19) |
|
||
|
|
Surgery | 35 (45) | 38 (49) |
|
28 (39) | 25 (38) |
|
31 (40) | 17 (31) |
|
||
| Patient volume, median (IQR) | 16 (6-51) | 10 (4-30) | .07 | 6 (3-14) | 4 (2-11) | .10 | 6 (2-29) | 9 (1-22) | .47 | |||
| Multisite physician, n (%) | 24 (31) | 19 (25) | .40 | 17 (24) | 16 (24) | .93 | 22 (29) | 19 (35) | .42 | |||
| Hub-hospital physician, n (%) | 44 (56) | 39 (51) | .47 | 45 (62) | 41 (62) | .96 | 56 (73) | 39 (72) | .95 | |||
| Ever used telehealth, n (%) | 2 (3) | 53 (69) | <.001 | 1 (1) | 33 (50) | <.001 | 2 (3) | 33 (61) | <.001 | |||